PHARMAC will use biggest budget increase ever to fund more medicines for more New Zealanders

19 May 2022 - PHARMAC welcomes the $191 million increase to its pharmaceutical budget over the next two years.  ...

Read more →

Budget 2022: two year old girl and mum travel to Wellington in hopes of getting funding for devastating spinal illness

19 May 2022 - Dozens of people are travelling to Wellington for the Budget to highlight concerns about sick children ...

Read more →

Cancer patient stares down the cost of buying time

18 May 2022 - It’s heartbreaking, frustrating, and it blows her mind. ...

Read more →

The drugs that give her life cost more than half the family's income

18 May 2022 - For Vickie Hudson-Craig,​ this year’s Budget could mean the difference between life and death. ...

Read more →

PHARMAC widens access to medicine for RSV

16 May 2022 - PHARMAC has announced today that it will be funding the preventative treatment, palivizumab, for the next two ...

Read more →

PHARMAC publishes agenda for May 2022 PTAC meeting

12 May 2022 - Yet another PTAC meeting with very few applications for new medicines/medicines still under patent protection. ...

Read more →

Calls for Health Minister to release final report from PHARMAC review

11 May 2022 - Health Minister Andrew Little is facing calls to release the final report from a review of ...

Read more →

People with multiple sclerosis unable to access 'life-changing' treatment in NZ

5 May 2022 - New Zealanders with multiple sclerosis say their only hope of slowing the disease is not available ...

Read more →

Mum and son hold their breath for cystic fibrosis drug Trikafta ahead of Budget

29 April 2022 - Hamish Mountfort is a smart, well-spoken and confident 22-year-old who’s dying, literally, to dedicate his life ...

Read more →

New Zealand Pharmaceutical Schedule - 1 May 2022

1 May 2022 - The May 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Cancer agency report duplicates PHARMAC role

28 April 2022 - The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected ...

Read more →

Access criteria for antiviral treatments widened as molnupiravir arrives in New Zealand

28 April 2022 - PHARMAC is widening access to the antivirals to treat people with early COVID-19, after receiving feedback from ...

Read more →

PHARMAC welcomes analysis into cancer medicines in Aotearoa

28 April 2022 - PHARMAC welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control ...

Read more →

Arthritis patients suffer after medication diverted due to COVID-19

27 April 2022 - Rheumatoid arthritis sufferers have been left in pain as one of their medications was diverted for ...

Read more →

8,700 more Pacific peoples need treatment to prevent gout each year to achieve equity

11 April 2022 - PHARMAC has released the Pacific peoples health – Gout data insights report today.  ...

Read more →